Bankrupt opioid manufacturer Purdue and the Sackler family have agreed to a $7.4 billion settlement to resolve opioid claims ...
After a federal guilty plea in 2020, the former OxyContin drugmaker is required to reemerge from Chapter 11 bankruptcy as a ...
Purdue Pharma on Wednesday filed a new Chapter 11 reorganization plan with the U.S. Bankruptcy Court for the Southern ...
In Harrington v. Purdue Pharma L.P., the Supreme Court held that the Bankruptcy Code does not authorize a bankruptcy court to ...
Copyright 2025 The Associated Press. All Rights Reserved. Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year ...
Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion in cash to creditors, subject to certain reserves, to compensate victims and abate the opioid crisis.
Purdue Pharma on Wednesday filed a new Chapter 11 reorganization plan with the U.S. Bankruptcy Court for the Southern District of New York to settle opioid-related claims involving the company for ...
Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin ...